Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,332 GBX | +0.55% | +1.45% | +16.34% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.34% | 238B | |
+32.84% | 698B | |
+26.51% | 568B | |
-4.59% | 358B | |
+19.58% | 328B | |
+3.50% | 283B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.92% | 165B | |
-2.39% | 160B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Transcript : AstraZeneca PLC, Q4 2022 Earnings Call, Feb 09, 2023